Renal denervation in moderate to severe CKD

Journal of the American Society of Nephrology

Volumn 23, Issue 7, 2012, Pages 1250-1257

  Hering, Dagmara ^a,b   Mahfoud, Felix ^c   Walton, Antony S ^d   Krum, Henry ^d   Lambert, Gavin W ^a   Lambert, Elisabeth A ^a   Sobotka, Paul A ^e,f   Böhm, Michael ^c   Cremers, Bodo ^c   Esler, Murray D ^a,d   Schlaich, Markus P ^a,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c SAARLAND UNIVERSITY   (Germany)

^d ALFRED HOSPITAL   (Australia)

^e UNIVERSITY OF MINNESOTA   (United States)

^f ARDIAN Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBON DIOXIDE; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RENIN INHIBITOR; VASODILATOR AGENT;

ADULT; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; HYPERTENSION; INCIDENTALOMA; KIDNEY ANGIOGRAPHY; KIDNEY BLOOD FLOW; KIDNEY DENERVATION; KIDNEY FUNCTION; MALE; NIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESISTANT HYPERTENSION; SLEEP APNEA SYNDROME; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE;

EID: 84863528992     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011111062     Document Type: Article

References (40)

1. Collins AJ, Li S, Ma JZ, Herzog C: Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis 38[Suppl 1]: S26-S29, 2001 (Pubitemid 32927607)
2. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl JMed 351: 1285-1295, 2004 (Pubitemid 39258422)
3. Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber MA, Franklin S, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T; ALLHAT Collaborative Research Group: Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 144: 172-180, 2006 (Pubitemid 46780689)
4. Herzog CA: Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. Kidney Int Suppl S197-S200, 2003
5. Multicentre, cross-sectional study of ventricular arrhythmias in chronically haemodialysed patients. Gruppo Emodialisi e Patologie Cardiovasculari. Lancet 2: 305-309, 1988
6. Gilbertson DT, Liu J, Xue JL, Louis TA, Solid CA, Ebben JP, Collins AJ: Projecting the number of patients with end-stage renal disease in the United States to the year 2015. JAm Soc Nephrol 16: 3736-3741, 2005 (Pubitemid 46211296)
7. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-1431, 1998 (Pubitemid 28405191)
8. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: Analysis of worldwide data. Lancet 365: 217-223, 2005 (Pubitemid 40138015)
9. Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, Esler MD, Lambert GW: Sympathetic activation in chronic renal failure. J Am Soc Nephrol 20: 933-939, 2009
10. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic overactivity in patients with chronic renal failure. N Engl JMed 327: 1912-1918, 1992 (Pubitemid 23006966)
11. Rump LC, Amann K, Orth S, Ritz E: Sympathetic overactivity in renal disease: A window to understand progression and cardiovascular complications of uraemia? Nephrol Dial Transplant 15: 1735-1738, 2000
12. Campese VM, Krol E: Neurogenic factors in renal hypertension. Curr Hypertens Rep 4: 256-260, 2002
13. Koomans HA, Blankestijn PJ, Joles JA: Sympathetic hyperactivity in chronic renal failure:Awake-up call. JAmSocNephrol 15: 524-537, 2004 (Pubitemid 38294782)
14. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS: Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105: 1354-1359, 2002 (Pubitemid 34260428)
15. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD: Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361: 932-934, 2009
16. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M: Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study. Lancet 373: 1275-1281, 2009
17. Symplicity HTN-1 Investigators: Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months. Hypertension 57: 911-917, 2011
18. Witkowski A, Prejbisz A, Florczak E, Ka̧dziela J, Śliwiński P, Bieleń P, Michałowska I, Kabat M, Warchoł E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A: Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 58: 559-565, 2011
19. Schlaich MP, Straznicky N, Grima M, Ika-Sari C, Dawood T, Mahfoud F, Lambert E, Chopra R, Socratous F, Hennebry S, Eikelis N, Böhm M, Krum H, Lambert G, Esler MD, Sobotka PA: Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens 29: 991-996, 2011
20. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M: Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 123: 1940-1946, 2011
21. Petidis K, Anyfanti P, Doumas M: Renal sympathetic denervation: Renal function concerns. Hypertension 58: e19, 2011
22. Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, Furiani S, Dell'Oro R, Mancia G: Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 57: 846-851, 2011
23. DiBona GF, Kopp UC: Neural control of renal function. Physiol Rev 77: 75-197, 1997
24. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M; Symplicity HTN-2 Investigators: Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. Lancet 376: 1903-1909, 2010
25. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G: Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 111: 1777-1783, 2005 (Pubitemid 40525142)
26. Fagard RH, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA: Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. J Hum Hypertens 23: 645-653, 2009
27. DiBona GF: The sympathetic nervous system and hypertension: Recent developments. Hypertension 43: 147-150, 2004
28. McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, Tse TF, Wasserman B, Leiserowitz M: The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 20: 1501-1510, 2004 (Pubitemid 39361354)
29. Li S, Collins AJ: Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients. Kidney Int 65: 626-633, 2004 (Pubitemid 38130658)
30. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W: Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: The ARIC Study. Kidney Int 64: 610-615, 2003 (Pubitemid 36871933)
31. Robertson D, Krantz SB, Biaggioni I: The anemia of microgravity and recumbency: Role of sympathetic neural control of erythropoietin production. Acta Astronaut 33: 137-141, 1994
32. Ditting T, Hilgers KF, Stetter A, Linz P, Schönweiss C, Veelken R: Renal sympathetic nerves modulate erythropoietin plasma levels after transient hemorrhage in rats. Am J Physiol Renal Physiol 293: F1099-F1106, 2007 (Pubitemid 47583942)
33. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD: Renal denervation as a therapeutic approach for hypertension: Novel implications for an old concept. Hypertension 54: 1195-1201, 2009
34. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Cottini E, Malatino LS; Creed Investigators: Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12: 1508-1515, 2001 (Pubitemid 32666334)
35. Marchais SJ, Guerin AP, Pannier BM, Levy BI, Safar ME, London GM: Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size. Hypertension 22: 876-883, 1993 (Pubitemid 23358096)
36. Tsioufis C, Tzioumis C, Marinakis N, Toutouzas K, Tousoulis D, Kallikazaros I, Stefanadis C, Toutouzas P: Microalbuminuria is closely related to impaired arterial elasticity in untreated patients with essential hypertension. Nephron Clin Pract 93: c106-c111, 2003
37. London GM, Blacher J, Pannier B, Guérin AP, Marchais SJ, Safar ME: Arterial wave reflections and survival in end-stage renal failure. Hypertension 38: 434-438, 2001 (Pubitemid 34225679)
38. Covic A, Mardare N, Gusbeth-Tatomir P, Prisada O, Sascau R, Goldsmith DJ: Arterial wave reflections and mortality in haemodialysis patients-only relevant in elderly, cardiovascularly compromised? Nephrol Dial Transplant 21: 2859-2866, 2006 (Pubitemid 44542243)
39. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B; Management of Arterial Hypertension of the European Society of Hypertension European Society of Cardiology: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).JHypertens 25: 1105-1187, 2007 (Pubitemid 46924065)
40. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999 (Pubitemid 29135798)